Its no wonder you may feel at the end of your rope
GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise
Monitoring and safety while taking semaglutide When taking semaglutide, your healthcare provider should closely monitor you to adjust dosing as needed to ensure efficacy and safety
Do body aches mean the medication is working
Ro's model bundles pharmacy fees, provider consultation, and medication delivery into monthly subscriptions, typically ranging from $99$299 depending on medication type and tier (per Ro's published rates as of July 2026)
In phase 2 trials, participants taking the highest dose of retatrutide experienced an average weight loss of approximately 24% over 48 weeks